Increases adiponectin secretion by 35 to 50%, improving insulin sensitivity and reducing inflammation Promotes lipolysis (fat breakdown) in a glucose-dependent manner, potentially overcoming the impaired lipolysis seen in lipedema fat Reduces pro-inflammatory adipokine production, including IL-6 and MCP-1 Enhances fatty acid oxidation in white adipose tissue, shifting the metabolic profile from storage to use These effects are distinct from and additive to the GLP-1 receptor-mediated appetite suppression and metabolic improvements
semaglutide is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
The experts behind O3 Smoothies Sara Fenn, MSc Founder & CEO A visionary in nutritional anthropology She applies insights from human evolutionary biology to modern nutrition protocols
This typically translates to 45-48 vials of 10mg product
Trial averages are not a guarantee of your own results
The trials compared tirzepatide to other diabetes medications, including semaglutide
